Evaluation of euroimmun anti-zika virus igm and igg enzyme-linked immunosorbent assays for zika virus serologic testing

Journal of Clinical Microbiology

Volumn 55, Issue 8, 2017, Pages 2462-2471

  L'Huillier, Arnaud G ^a   Hamid Allie, Anne ^b   Kristjanson, Erik ^b   Papageorgiou, Louis ^b   Hung, Sam ^b   Wong, Chun Fai ^b   Stein, Derek R ^c   Olsha, Romy ^b   Goneau, Lee W ^b,d   Dimitrova, Kristina ^c   Drebot, Mike ^c   Safronetz, David ^c   Gubbay, Jonathan B ^a,b,d  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b PUBLIC HEALTH ONTARIO   (Canada)

^c PUBLIC HEALTH AGENCY OF CANADA   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

Author keywords

Diagnostic testing; Epidemic; Flavivirus; Serology; Zika virus

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; VIRUS ANTIBODY;

ADULT; ARTICLE; CANADA; COHORT ANALYSIS; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOASSAY ANALYZER; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; VIRUS NEUTRALIZATION; ZIKA VIRUS; BLOOD; COMPARATIVE STUDY; EVALUATION STUDY; IMMUNOLOGY; MIDDLE AGED; ONTARIO; PREGNANCY; PROCEDURES; SEROLOGY; ZIKA FEVER;

ADULT; ANTIBODIES, VIRAL; COHORT STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MALE; MIDDLE AGED; ONTARIO; PREGNANCY; SENSITIVITY AND SPECIFICITY; SEROLOGIC TESTS; ZIKA VIRUS; ZIKA VIRUS INFECTION;

EID: 85026239428     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.00442-17     Document Type: Article

References (21)

1. Kuno G, Chang GJ. 2007. Full-length sequencing and genomic characterization of Bagaza, Kedougou, and Zika viruses. Arch Virol 152: 687-696. https://doi.org/10.1007/s00705-006-0903-z.
2. Duffy MR, Chen TH, Hancock WT, Powers AM, Kool JL, Lanciotti RS, Pretrick M, Marfel M, Holzbauer S, Dubray C, Guillaumot L, Griggs A, Bel M, Lambert AJ, Laven J, Kosoy O, Panella A, Biggerstaff BJ, Fischer M, Hayes EB. 2009. Zika virus outbreak on Yap Island, Federated States of Micronesia. N Engl J Med 360:2536-2543. https://doi.org/ 10.1056/NEJMoa0805715.
3. Cao-Lormeau VM, Roche C, Teissier A, Robin E, Berry AL, Mallet HP, Sall AA, Musso D. 2014. Zika virus, French Polynesia, South Pacific, 2013. Emerg Infect Dis 20:1085-1086. https://doi.org/10.3201/ eid2006.140138.
4. Cao-Lormeau VM, Musso D. 2014. Emerging arboviruses in the Pacific. Lancet 384:1571-1572. https://doi.org/10.1016/S0140-6736(14)61977-2.
5. Tognarelli J, Ulloa S, Villagra E, Lagos J, Aguayo C, Fasce R, Parra B, Mora J, Becerra N, Lagos N, Vera L, Olivares B, Vilches M, Fernandez J. 2016. A report on the outbreak of Zika virus on Easter Island, South Pacific, 2014. Arch Virol 161:665-668. https://doi.org/10.1007/s00705-015-2695-5.
6. Campos GS, Bandeira AC, Sardi SI. 2015. Zika Virus Outbreak, Bahia, Brazil. Emerg Infect Dis 21:1885-1886. https://doi.org/10.3201/eid2110 .150847.
7. Lanciotti RS, Kosoy OL, Laven JJ, Velez JO, Lambert AJ, Johnson AJ, Stanfield SM, Duffy MR. 2008. Genetic and serologic properties of Zika virus associated with an epidemic, Yap State, Micronesia, 2007. Emerg Infect Dis 14:1232-1239. https://doi.org/10.3201/eid1408.080287.
8. Bingham AM, Cone M, Mock V, Heberlein-Larson L, Stanek D, Blackmore C, Likos A. 2016. Comparison of test results for Zika virus RNA in urine, serum, and saliva specimens from persons with travel-associated Zika virus disease-Florida, 2016. MMWR Morb Mortal Wkly Rep 65:475-478. https://doi.org/10.15585/mmwr.mm6518e2.
9. Centers for Disease Control and Prevention. 2016. Guidance for U.S. laboratories testing for Zika virus infection. Centers for Disease Control and Prevention, Atlanta, GA.
10. Oduyebo T, Igbinosa I, Petersen EE, Polen KN, Pillai SK, Ailes EC, Villanueva JM, Newsome K, Fischer M, Gupta PM, Powers AM, Lampe M, Hills S, Arnold KE, Rose LE, Shapiro-Mendoza CK, Beard CB, Munoz JL, Rao CY, Meaney-Delman D, Jamieson DJ, Honein MA. 2016. Update: interim guidance for health care providers caring for pregnant women with possible Zika virus exposure-United States, July 2016. MMWR Morb Mortal Wkly Rep 65:739-744. https://doi.org/10 .15585/mmwr.mm6529e1.
11. Macnamara FN, Horn DW, Porterfield JS. 1959. Yellow fever and other arthropod-borne viruses; a consideration of two serological surveys made in South Western Nigeria. Trans R Soc Trop Med Hyg 53:202-212. https://doi.org/10.1016/0035-9203(59)90072-0.
12. Martin DA, Muth DA, Brown T, Johnson AJ, Karabatsos N, Roehrig JT. 2000. Standardization of immunoglobulin M capture enzyme-linked immunosorbent assays for routine diagnosis of arboviral infections. J Clin Microbiol 38:1823-1826.
13. Food and Drug Administration. 2016. Emergency use authorization: Zika MAC-ELISA (CDC). Food and Drug Administration, Washington, DC. http:// www.fda.gov/downloads/MedicalDevices/Safety/EmergencySituations/ UCM488040.pdf. Accessed 22 March 2017.
14. Rabe IB, Staples JE, Villanueva J, Hummel KB, Johnson JA, Rose L, Mts Hills S, Wasley A, Fischer M, Powers AM. 2016. Interim guidance for interpretation of Zika virus antibody test results. MMWR Morb Mortal Wkly Rep 65:543-546. https://doi.org/10.15585/mmwr.mm6521e1.
15. Granger D, Gómez LJ, Schimek M, Dubbels M, Mosquera JA, Christensen J, Bistodeau S, Strain A, Theel ES. 2016. Zika virus antibody detection: evaluation of three different serologic methodologies. Abstr 32nd Clin Virol Symp, Daytona Beach, Florida, USA.
16. Euroimmun AG. 2016. Euroimmun anti-Zika virus ELISA IgM & IgG. https:// www.euroimmun.com/documents/Indications/Infections/Zika-virus/HI-2668-I-UK-B.pdf. Accessed 22 March 2017.
17. Huzly D, Hanselmann I, Schmidt-Chanasit J, Panning M. 2016. High specificity of a novel Zika virus ELISA in European patients after exposure to different flaviviruses. Euro Surveill 21:30203. http://www.eurosurveillance .org/ViewArticle.aspx?ArticleId-21450.
18. Steinhagen K, Probst C, Radzimski C, Schmidt-Chanasit J, Emmerich P, van Esbroeck M, Schinkel J, Grobusch MP, Goorhuis A, Warnecke JM, Lattwein E, Komorowski L, Deerberg A, Saschenbrecker S, Stocker W, Schlumberger W. 2016. Serodiagnosis of Zika virus (ZIKV) infections by a novel NS1-based ELISA devoid of cross-reactivity with dengue virus antibodies: a multicohort study of assay performance, 2015 to 2016. Euro Surveill 21:30426. http:// www.eurosurveillance.org/ViewArticle.aspx?ArticleId-22670.
19. Public Health Ontario Laboratories. 2017. Public Health Ontario's Zika virus-test information sheet. https://www.publichealthontario.ca/en/ ServicesAndTools/LaboratoryServices/Documents/Testing-directions-and-algorithms-for-patients-suspected-of-Zika-infection.pdf. Accessed 5 May 2017.
20. Calisher CH, Karabatsos N, Dalrymple JM, Shope RE, Porterfield JS, Westaway EG, Brandt WE. 1989. Antigenic relationships between flaviviruses as determined by cross-neutralization tests with polyclonal antisera. J Gen Virol 70:37-43. https://doi.org/10.1099/0022-1317-70-1-37.
21. L'Huillier AG, Lombos E, Tang E, Perusini S, Eshaghi A, Nagra S, Frantz C, Olsha R, Kristjanson E, Dimitrova K, Safronetz D, Drebot M, Gubbay JB. 2017. Evaluation of Altona Diagnostics RealStar Zika virus RT-PCR test kit for Zika virus PCR testing. J Clin Microbiol 55:1576-1584. https://doi.org/ 10.1128/JCM.02153-16.